-transparent.png){kind=logo}
Serial frozen sections were prepared from 22 squamous cell carcinomas of oral cavity and paranasal sinus. Mononuclear cell infiltrates were stained by the biotin-avidin-horseradish peroxidase method using a panel of 10 mouse monoclonal antibodies to human leukocyte antigens. The degree of infiltration was graded from + + + (marked) to - (absent). The infiltration of anti-Leu-4-reactive cells (Leu-4+ cells) was grade + + or + + + in 14 of 22 cases. In 13 of 22 cases, infiltration of Leu-3a + 3b+ cells (helper/inducer T lymphocytes) was grade + + (moderate). In 5 of 20 cases, infiltration of Leu-2a+ cells (cytotoxic/suppressor T lymphocytes) was grade + +. As for B lymphocytes, infiltration of Leu-12+ cells was grade + + in only 2 of 19 cases. In conclusion, T lymphocyte infiltrates were commonly seen in squamous cell carcinoma in oral cavity and paranasal sinus and the number of patients with grade + + infiltration of helper/inducer T lymphocytes significantly predominated over that of patients with infiltration of cytotoxic/suppressor T lymphocytes grade + +.
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
January 1990,
Head & neck,
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
December 2013,
Polish journal of pathology : official journal of the Polish Society of Pathologists,
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
January 1996,
Anticancer research,
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
October 2002,
Oral oncology,
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
July 2018,
Pathology oncology research : POR,
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
January 1994,
European journal of cancer. Part B, Oral oncology,
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
January 2017,
Clinics in dermatology,
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
September 1997,
Oral oncology,
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
August 2015,
Cellular and molecular biology (Noisy-le-Grand, France),
Y Ogawa, and
T Maeda, and
H Seguchi, and
S Yoshida, and
T Inomata, and
F Hamada, and
S Kishimoto, and
H Saito, and
T Osaki
October 2021,
Hematology/oncology clinics of North America,
